SABCS 2020: Managing Breast Cancer During the COVID-19 Pandemic
As we approach the end of the year that was consumed by the pandemic, more than 68 million people...
As we approach the end of the year that was consumed by the pandemic, more than 68 million people...
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
It is estimated that almost 40 percent of people in the United States will be diagnosed with cancer during their lifetimes and...
Cancer is often described as a disease of old age. However, certain cancers have become increasingly prevalent among younger populations...
Editor’s note: When the San Antonio Breast Cancer Symposium (SABCS) kicks off next week, researchers will present the results...
Breast cancer can be a scary diagnosis. Even though mortality rates have declined in recent years in the United...
The AACR Project Genomics Evidence Neoplasia Information Exchange (AACR Project GENIE) is a unique registry that aggregates, harmonizes, and...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
Therapeutics that target two proteins called cyclin-dependent kinase 4 (CDK4) and CDK6 have revolutionized treatment for breast cancer, Richard...
The AACR Annual Meeting 2019 features the theme “Integrative Cancer Science • Global Impact • Individualized Patient Care.” That theme provided...